PGRN mediates the crosstalk between ovarian cancer cells and CAFs and reshapes tumor immune microenvironment
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115362 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Xin Ning und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical Col…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Progranulins, Ovarian Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Chinese Academy of Sciences, Heilongjiang Province Natural Science Foundation, China Primary Health Care Foundation.
Abstract (Originalsprache)
The tumor microenvironment (TME) serves crucial functions in ovarian cancer progression through complex interactions between tumor cells and stromal cells, particularly cancer-associated fibroblasts (CAFs). However, tumor-stroma interactions in ovarian cancer remain poorly characterized. Here, we identified progranulin (PGRN) as a key TME mediator that promotes crosstalk between tumor cells and CAFs, contributing to an immunosuppressive microenvironment. First, we discovered that PGRN deficiency in tumor cells attenuated malignant phenotypes and orthotopic tumor growth, while also suppressing CAF activation. Conversely, CAF-derived PGRN promoted tumor proliferation and invasion, while fibroblast-specific ablation of PGRN markedly suppressed tumor growth in vivo. Remarkably, PGRN in the TME rejected intratumoral CD8+ T cell infiltration, augmented the expression of programmed cell death 1 (PD-1), thereby fostering an immunosuppressive TME. Moreover, in human ovarian cancer tissues, PGRN expression was upregulated and positively correlated with CAFs abundance. High expression of PGRN correlated with poor overall survival in human ovarian cancer. Collectively, these findings highlight PGRN as a vital regulator of tumor-CAF interactions and a promising target for TME-directed therapies in ovarian cancer, emphasizing its therapeutic potential for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Medicine, Department of Gynecology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, China; Zhejiang Cancer Hospital, Hangzhou I…
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Medical College of Tianjin University, Tianjin University, Tianjin 300072, China.
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
- Department of Gynecology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, 325027,…
- Department of Radiation Biology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, AMMS, 100850, Beijing, China.
Förderung
- Chinese Academy of Sciences
- Heilongjiang Province Natural Science Foundation
- China Primary Health Care Foundation
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Ning, X., Wang, Y., Zhai, L., Gao, W., Jin, Z., Iqbal, H., Ur-Rehman, U., Gao, L., Lv, M., Yuan, Z., Yi, Z., Wang, B., Chen, W., Ma, R., & Xiao, R. (2025). PGRN mediates the crosstalk between ovarian cancer cells and CAFs and reshapes tumor immune microenvironment. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115362
Vancouver
Ning X, Wang Y, Zhai L, Gao W, Jin Z, Iqbal H, et al. PGRN mediates the crosstalk between ovarian cancer cells and CAFs and reshapes tumor immune microenvironment. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115362
BibTeX
@article{Ning2025,
author = {Ning, Xin and Wang, Yue and Zhai, Lina and Gao, Wen and Jin, Zihui and Iqbal, Haroon and Ur-Rehman, Uzair and Gao, Lei and Lv, Man and Yuan, Ziyin and Yi, Zhou and Wang, Baichuan and Chen, Wangkai and Ma, Rong and Xiao, Run},
title = {PGRN mediates the crosstalk between ovarian cancer cells and CAFs and reshapes tumor immune microenvironment},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115362}
}
EUVIMED